NCI and FDA Announce Joint Program to Streamline Cancer Drug Development

First Page		Document Content
Pharmacology Cancer research National Institutes of Health Andrew von Eschenbach National Cancer Institute Food and Drug Administration War on Cancer James L. Gulley Medicine Health Cancer organizations		NCI and FDA Announce Joint Program to Streamline Cancer Drug Development Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 29,19 KB Share Document on Facebook

	Cell Biology and Cancer under a contract from the National Institutes of Health in collaboration with the National Cancer Institute DocID: 1vqc4 - View Document
	Checklist for Easy-to-Read Informed Consent Text (Adapted from National Cancer Institute, Bethesda, MD) Words are familiar to the reader or are clearly defined and are used consistently throughout DocID: 1uNbT - View Document
	National Cancer Institute (NCI)/Division of Cancer Treatment and Diagnosis (DCTD) Conflict of Interest Policy for NCI/DCTD-supported Cooperative Group or National Clinical Trials Network Randomized Phase 2 and Phase 3 Cl DocID: 1uHwr - View Document
	Oncology over Internet: integrating data and analysis of oncology interest on the net by means of workflows Paolo Romano () National Cancer Research Institute, Genoa, Italy DocID: 1uuc1 - View Document
	National Cancer Institute Understanding Chemotherapy What is chemotherapy? Chemotherapy is a cancer treatment DocID: 1uhTU - View Document